BridgeBio Pharma Inc — 四半期キャッシュフロー (NASDAQ:BBIO) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

総資産 919.34 M881.64 M1.08 B998.25 M936.02 M 負債合計 2.38 B2.52 B2.86 B2.92 B3.01 B 純資産合計 -1.46 B-1.64 B-1.78 B-1.92 B-2.08 B 負債および純資産合計 919.34 M881.64 M1.08 B998.25 M936.02 M 有利子負債合計 437.34 M002.02 B2.02 B 純負債 -243.76 M-540.6 M-756.89 M1.37 B1.43 B

ニュース

TechnipFMC Defies Market, Hits Record High, Leads 16 Top Performers To IBD Best Stock Lists

Oil Major EQT Pops To Record High, Leads 23 Hot Names New To Best Stock Lists

Tracking Ole Andreas Halvorsen’s Viking Global Portfolio – Q4 2025 Update

Can Alnylam's Pipeline Drugs Sustain Long-Term Growth Ahead?

Monday’s insider activity: Vail Resorts CEO buys $4.9 million

PGIM Jennison Health Sciences Fund Q4 2025 Key Contributors And Detractors

Leerink PartnersがBridgeBio株に対して目標株価98ドルでアウトパフォーム評価を継続

Leerink Partners reiterates Outperform on BridgeBio stock at $98

BridgeBio Pharma, Inc. (BBIO) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

BridgeBio、LGMD2I/R9治療薬の良好な中間データを発表

BridgeBio presents positive interim data for LGMD2I/R9 therapy

JPMorgan adds BridgeBio to focus list, lifts target to $94